Icon
+91 94997 68112
Login Register

OGSIVEO (NDA217677)- (EQ 50MG BASE,EQ 100MG BASE,EQ 150MG BASE)

NIROGACESTAT HYDROBROMIDE SPRINGWORKS
EQ 50MG BASE,EQ 100MG BASE,EQ 150MG BASE
No No
2043-May-19 2028-Nov-27
None None
None No
OGSIVEO is a gamma secretase inhibitor indicated for adult patients with progressing desmoid tumors who require systemic treatment.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 50MG BASE ** ** - - -
EQ 100MG BASE ** ** - - -
EQ 150MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.